doi:10.1007/s12250-012-3284-3

[1]
徐宜英*, 任莉莉, 2004: Detection of HBV Mutation Associated with Lamivudine By Gene Chips, Virologica Sinica, 19, 410-412.
[2]
Zhi-ying OU, Rong ZHOU, Yun-shao HE, 2008: YVDD Mutation of Hepatitis B Virus, a Dominant Lamivudine-Resistant Type in Guangzhou, South China, Virologica Sinica, 23, 218-225. doi: 10.1007/s12250-008-2963-6
[3]
高英堂, 陈瑞阳, 宋文芹, 陈成彬, 齐之丽, 景丽, 孙金英, 钱绍诚, 2003: DNA M icroarray for M onitoring Genetic Variability ofHepatitis B virus during Lamivudine Therapy, Virologica Sinica, 18, 523-529.
[4]
Chunchen Wu, Hui Shi, Mengji Lu, Yang Xu, Xinwen Chen, 2013: A Case of Hepatitis B Reactivation in an Anti-HBs Positive, Anti-HBc Positive non-Hodgkins Lymphoma Patient, Virologica Sinica, 28, 49-52. doi: 10.1007/s12250-013-3285-x
[5]
Guo-hui Chang, Bao-jun Luo, Pin Lu, Lei Lin, Xiao-yan Wu, Jing Li, Yi Hu, Qing-yu Zhu, 2011: Construction and Genetic Analysis of Murine Hepatitis Virus Strain A59 Nsp16 Temperature Sensitive Mutant and the Revertant Virus, Virologica Sinica, 26, 19-29. doi: 10.1007/s12250-011-3145-x
[6]
Haoneng Tang, Yong Ke, Yunji Liao, Yanlin Bian, Yunsheng Yuan, Ziqi Wang, Li Yang, Hang Ma, Tao Sun, Baohong Zhang, Xiaoju Zhang, Mingyuan Wu, Jianwei Zhu, 2022: Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helix, Virologica Sinica, 37, 860-873. doi: 10.1016/j.virs.2022.11.005
[7]
巫振欧, 管美英, 林胜清, 吴章琦, 1987: EFFICACY OF HUMAN LEUKOCYTESINTERFERON IN CHRONIC HEPATITIS B, Virologica Sinica, 2, 45-.
[8]
郭亚兵, 侯金林, 戴炜, 骆抗先, P.Karayiannis, 1999: Sequencing of the W hole Gene of Hepatitis B Virus, Virologica Sinica, 14, 205-209.
[9]
熊开钧, 王心禾, 黄华芳, 姚梦林, 代家珠, 金慰鄂, 范红梅, 曾全兰, 张雪珍, 1987: THE OBSERVATION OF A TREATED RESULT WITH ACYCLOVIR IN HEPATITIS B VIRUS, Virologica Sinica, 2, 78-.
[10]
熊开钧, 黄华芳, 王心禾, 金慰鄂, 曾令兰, 杨泽川, 凌美霞, 张雪珍, 吴章琦, 1987: THE TREATMENT EFFECT OF HEPATITIS B WITH INTERFERON AND ACYCLOVIR, Virologica Sinica, 2, 17-.
[11]
范涛, 傅希贤, 张国庆, 张乃临, 1994: The Inhibitory Effects of Quinolones on Hepatitis B Virus in Vitro, Virologica Sinica, 9, 113-118.
[12]
Jianhao Cao, Shuhong Luo, Yuanyan Xiong, 2019: The Variability of Amino Acid Sequences in Hepatitis B Virus, Virologica Sinica, 34, 42-49. doi: 10.1007/s12250-018-0070-x
[13]
Felicia Tucci, Ralf Küppers, 2014: Role of hepatitis C virus in B cell lymphoproliferations, Virologica Sinica, 29, 3-6. doi: 10.1007/s12250-014-3414-1
[14]
Ju-sheng LIN, Lin-lin GAO, 2008: Advances in Research on Hepatitis B Virus DNA Integration, Virologica Sinica, 23, 93-99. doi: 10.1007/s12250-008-2939-6
[15]
Yang XU, Chun-wei SHE, Xiao-yong ZHANG, Rong-juan PEI, Meng-ji LU, 2008: Interference of Hepatitis B Virus with Cellular Signaling^*, Virologica Sinica, 23, 100-106. doi: 10.1007/s12250-008-2940-0
[16]
吴婷, 黄海, 1998: The Inhibitory Effects of Enduracidin on Hepatitis B Virus in vitro, Virologica Sinica, 13, 45-.
[17]
Yin-ping LU, Bao-ju WANG, Ji-hua DONG, Zhao LIU, Shi-he GUAN, Meng-ji LU, Dong-liang YANG, 2007: Construction and Characterization of a Hepatitis B Virus Replicon, Virologica Sinica, 22, 8-13.
[18]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B^*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9
[19]
严亚琼, 陈冬峨, 曾艳彩, , , , 2004: Study on Risk Relationship between Hepatitis B Virus and Primary Hepatocellular Carcinoma, Virologica Sinica, 19, 549-552.
[20]
季伟, 王勤环, 斯崇文, 于敏, 张国庆, 刘丹, 1999: Inhibition of Hepatitis B Virus by Retroviral Vectors Expressing Antisenses PreS／S, Virologica Sinica, 14, 310-313.